TScan Therapeutics Inc. (TCRX)
NASDAQ · Healthcare
TScan Therapeutics Inc. Revenue 2020–2025
TScan Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- TScan Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 982000, a 54.77% decrease year-over-year.
- TScan Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 8.7 M, a 44.75% increase year-over-year.
- TScan Therapeutics Inc. annual revenue for 2025 was 10.3 M, a 266.65% increase from 2024.
- TScan Therapeutics Inc. annual revenue for 2024 was 2.8 M, a 86.62% decrease from 2023.
- TScan Therapeutics Inc. annual revenue for 2023 was 21.0 M, a 55.52% increase from 2022.
- TScan Therapeutics Inc. annual revenue for 2022 was 13.5 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TScan Therapeutics Inc. Market Cap — FAQ
TScan Therapeutics Inc. (TCRX) market cap over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TCRX's market cap history?
The chart and table above show TScan Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.